{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:18:25Z","timestamp":1792189105311,"version":"4.4.0"},"reference-count":24,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Uterine leiomyosarcoma (LMS) is a rare entity amongst malignant gynaecological tumours and is mostly diagnosed after surgery for benign leiomyoma (LM) of the uterus. As minimal invasive surgery is widely used, the morcellation of LM and the uterus is rather common. As there is little known about the impact of the morcellation of LMS on local and distant metastases, as well as overall survival, we carried out a large-scale retrospective study. Methods: A total of 301 LMS cases from the German Clinical Competence Centre for Genital Sarcomas and Mixed Tumours were analysed. We distinguished morcellated and non-morcellated LMS from pT1 and &gt;pT1 tumours. Fine\u2013Gray competing risks regressions and cumulative incidence rates were computed for the time to local recurrence, distant metastases, and patient death. Results: The recurrence free interval in pT1 LMS was significantly lower in the morcellation group with a 2-year cumulative incidence rate of 49% vs. 26% in non-morcellated LMS (p = 0.001). No differences were seen in &gt;pT1 tumours. Distant metastases were more frequently found in non-morcellated pT1 LMS compared to the morcellated cases (5-year cumulative incidence: 54% vs. 29%, p &lt; 0.001). There was no significant difference in time to death between both groups neither in the pT1 stages nor in &gt;pT1 disease. Subdistribution hazard ratios estimated by multivariable competing risks regressions for the morcellation of pT1 LMS were 2.11 for local recurrence (95% CI 1.41\u20133.16, p &lt; 0.001) and 0.52 for distant metastases (95% CI 0.32\u20130.84, p = 0.008). Conclusions: Tumour morcellation is not associated with OS for pT1 tumours. The morcellation of pT1 LMS seems to prolong the time to distant metastases whereas local recurrence is more likely to occur after the morcellation of pT1 LMS.<\/jats:p>","DOI":"10.3390\/jcm12020591","type":"journal-article","created":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T03:11:02Z","timestamp":1673493062000},"page":"591","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Accidental Morcellation of Uterine Leiomyosarcoma Influences Relapse Free Survival but Does Not Negatively Influence Overall Survival"],"prefix":"10.3390","volume":"12","author":[{"given":"Verena M. C.","family":"Reichert","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynaecology, University Medicine Greifswald, Ferdinand-Sauerbruch-Stra\u00dfe, 17475 Greifswald, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0743-9692","authenticated-orcid":false,"given":"Zaher","family":"Alwafai","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, University Medicine Greifswald, Ferdinand-Sauerbruch-Stra\u00dfe, 17475 Greifswald, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek T.","family":"Zygmunt","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, University Medicine Greifswald, Ferdinand-Sauerbruch-Stra\u00dfe, 17475 Greifswald, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4593-2026","authenticated-orcid":false,"given":"Marcus","family":"Vollmer","sequence":"additional","affiliation":[{"name":"Institute of Bioinformatics, University Medicine Greifswald, Felix-Hausdorff-Str. 8, 17475 Greifswald, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcnter","family":"K\u00f6hler","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, University Medicine Greifswald, Ferdinand-Sauerbruch-Stra\u00dfe, 17475 Greifswald, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2147\/IJWH.S51083","article-title":"Uterine fibroids: Current perspectives","volume":"6","author":"Khan","year":"2014","journal-title":"Int. J. Womens Health"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1007\/s00404-019-05344-0","article-title":"Benign uterine mass-discrimination from leiomyosarcoma by a preoperative risk score: A multicenter cohort study","volume":"300","author":"Kohler","year":"2019","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2414609","DOI":"10.1155\/2018\/2414609","article-title":"A Comprehensive Review of the Pharmacologic Management of Uterine Leiomyoma","volume":"2018","author":"Lewis","year":"2018","journal-title":"Biomed. Res. Int."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.ygyno.2018.09.010","article-title":"Uterine leiomyosarcoma: A review of the literature and update on management options","volume":"151","author":"Roberts","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1111\/aogs.12930","article-title":"Uterine leiomyosarcoma\u2014Incidence, treatment, and the impact of morcellation. A nationwide cohort study","volume":"95","author":"Skorstad","year":"2016","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ygyno.2009.09.023","article-title":"Uterine sarcomas: A review","volume":"116","author":"Prat","year":"2010","journal-title":"Gynecol. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ygyno.2017.02.012","article-title":"Prognosis and treatment of uterine leiomyosarcoma: A National Cancer Database study","volume":"145","author":"Seagle","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/IGC.0000000000000911","article-title":"European Society of Gynecological Oncology Statement on Fibroid and Uterine Morcellation","volume":"27","author":"Halaska","year":"2017","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/AOG.0000000000000448","article-title":"Intracorporeal electromechanical tissue morcellation: A critical review and recommendations for clinical practice","volume":"124","author":"Kho","year":"2014","journal-title":"Obstet. Gynecol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1111\/j.1525-1438.2007.01126.x","article-title":"Management of uterine malignancy found incidentally after supracervical hysterectomy or uterine morcellation for presumed benign disease","volume":"18","author":"Einstein","year":"2008","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00404-015-3696-z","article-title":"Malignancy rate of 10,731 uteri morcellated during laparoscopic supracervical hysterectomy (LASH)","volume":"292","author":"Bojahr","year":"2015","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10397-015-0878-4","article-title":"Options on fibroid morcellation: A literature review","volume":"12","author":"Brolmann","year":"2015","journal-title":"Gynecol. Surg."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10397-015-0894-4","article-title":"The prevalence of occult leiomyosarcoma at surgery for presumed uterine fibroids: A meta-analysis","volume":"12","author":"Pritts","year":"2015","journal-title":"Gynecol. Surg."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1634\/theoncologist.2014-0361","article-title":"Age-stratified risk of unexpected uterine sarcoma following surgery for presumed benign leiomyoma","volume":"20","author":"Brohl","year":"2015","journal-title":"Oncologist"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.jmig.2015.08.013","article-title":"Laparoscopic Supracervical Hysterectomy or Myomectomy with Power Morcellation: Risk of Uterine Leiomyosarcomas. A Retrospective Trial Including 35.161 Women in Germany","volume":"22","author":"Nugent","year":"2015","journal-title":"J. Minim. Invasive Gynecol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ygyno.2016.11.002","article-title":"Morcellation worsens survival outcomes in patients with undiagnosed uterine leiomyosarcomas: A retrospective MITO group study","volume":"144","author":"Raspagliesi","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ygyno.2014.11.011","article-title":"Impact of morcellation on survival outcomes of patients with unexpected uterine leiomyosarcoma: A systematic review and meta-analysis","volume":"137","author":"Bogani","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.jmig.2014.04.012","article-title":"Electric motorized morcellator versus transvaginal extraction for myoma retrieval after laparoscopic myomectomy: A propensity-matched analysis","volume":"21","author":"Bogani","year":"2014","journal-title":"J. Minim. Invasive Gynecol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ygyno.2011.04.021","article-title":"The impact of tumor morcellation during surgery on the prognosis of patients with apparently early uterine leiomyosarcoma","volume":"122","author":"Park","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"ref_20","first-page":"237","article-title":"Prognostic value of initial surgical procedure for patients with uterine sarcoma: Analysis of 123 patients","volume":"24","author":"Morice","year":"2003","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.jmig.2016.01.019","article-title":"Impact of the 2014 Food and Drug Administration Warnings Against Power Morcellation","volume":"23","author":"Lum","year":"2016","journal-title":"J. Minim. Invasive Gynecol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/IGC.0b013e31819a1f8f","article-title":"Uterine leiomyosarcoma: Does the primary surgical procedure matter?","volume":"19","author":"Perri","year":"2009","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1002\/cncr.28844","article-title":"Retrospective cohort study evaluating the impact of intraperitoneal morcellation on outcomes of localized uterine leiomyosarcoma","volume":"120","author":"George","year":"2014","journal-title":"Cancer"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-018-5156-1","article-title":"Management of uterine sarcomas and prognostic indicators: Real world data from a single-institution","volume":"18","author":"Kyriazoglou","year":"2018","journal-title":"BMC Cancer"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/2\/591\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:03:16Z","timestamp":1760119396000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/2\/591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,11]]},"references-count":24,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["jcm12020591"],"URL":"https:\/\/doi.org\/10.3390\/jcm12020591","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,11]]}}}